Acepodia Valuation Multiples

Acepodia Overview

About Acepodia

Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Founded

2017

HQ

Employees

N/A

Website

acepodia.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $6K

EBITDA: ($20M)

EV

$117M

Valuation Multiples

Multiples.vc

Start free trial

Acepodia Financials

Acepodia reported last fiscal year revenue of $6K and negative EBITDA of ($20M).

In the same fiscal year, Acepodia generated $4K in gross profit, ($20M) in EBITDA losses, and had net loss of ($24M).

Acepodia P&L

In the most recent fiscal year, Acepodia reported revenue of $6K and EBITDA of ($20M).

Acepodia expects next 12-month revenue of XXX and NTM EBITDA of XXX

Acepodia Stock Performance

Acepodia has current market cap of $229M, and enterprise value of $117M.

Acepodia's stock price is $0.39.

Acepodia Valuation Multiples

Acepodia trades at 19806.9x EV/Revenue multiple, and (5.7x) EV/EBITDA.

Acepodia Financial Valuation Multiples

As of April 27, 2026, Acepodia has market cap of $229M and EV of $117M.

Equity research analysts estimate Acepodia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Acepodia has a P/E ratio of (9.6x).

Acepodia Margins & Growth Rates

Acepodia's revenue in the last fiscal year declined by (57%).

Acepodia Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Acepodia M&A Activity

Acepodia acquired XXX companies to date.

Last acquisition by Acepodia was on XXXXXXXX, XXXXX. Acepodia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Acepodia Investment Activity

Acepodia invested in XXX companies to date.

Acepodia made its latest investment on XXXXXXXX, XXXXX. Acepodia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).